BPD app trial halted: what happened?

NCT ID NCT06601907

First seen Mar 22, 2026 · Last updated Jun 24, 2026 · Updated 19 times

Summary

This study tested alivis, a smartphone app that teaches coping skills for borderline personality disorder (BPD). It was designed for people aged 18-65 with BPD, who used the app alongside their usual treatment. The goal was to see if the app reduces BPD symptoms, depression, and anxiety. However, the trial was terminated early, so we don't have clear results on its effectiveness.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BORDERLINE PERSONALITY DISORDER (BPD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • GAIA

    Hamburg, 22085, Germany

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

alivis digital health application

What this could lead to

If it had succeeded, this could point toward a convenient, app-based way to help manage BPD symptoms alongside usual care.

What could go wrong

The trial was terminated early, so results are not available. Digital interventions may not work for everyone, and this was an unguided program.

Conditions

The condition(s) this trial relates to.

borderline personality disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.